Concepedia

Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer

EF Solomayer, IJ Diel, D. Wallwiener, Sebastian F. N. Bode, G. Meyberg, Martin Sillem, Christina Gollan, MD Kramer, U. Krainick, G. Bastert

British Journal of Cancer · 1997 · 44 citations · 32 references

DOIFull text

Open access

Concepts

References

32

Differential Expression of Proliferation-Associated Molecules in Individual Micrometastatic Carcinoma Cells

Klaus Pantel, Günter Schlimok, Stephan Braun et al. · JNCI Journal of the National Cancer Institute · 1993 · 515 citations

, , +17

Micrometastatic Breast Cancer Cells in Bone Marrow at Primary Surgery: Prognostic Value in Comparison With Nodal Status

Ingo Diel, M. Kaufmann, Serban Dan Costa et al. · JNCI Journal of the National Cancer Institute · 1996 · 488 citations

, , +13

A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.

Paul R. Rosen, Susan Groshen, Patricia E. Saigo et al. · Journal of Clinical Oncology · 1989 · 444 citations

, , +17

Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.

R. J. Cote, Paul Peter Rosen, Martin Lesser et al. · Journal of Clinical Oncology · 1991 · 443 citations

, , +16

High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis.

J Grøndahl-Hansen, I. J. Christensen, Christian Rosenquist et al. · PubMed · 1993 · 390 citations

, , +13